carnitine has been researched along with Liver Diseases in 56 studies
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In conclusion, our data supports a protective effect of L-carnitine against oxidative damage in hepatic ischemia-reperfusion injury in rats." | 7.79 | The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. ( Aldemır, D; Boyacioğlu, S; Çekın, AH; Gür, G; Gürsoy, M; Taşkoparan, M; Türkoğlu, S; Yilmaz, U, 2013) |
| "Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a mitochondrial fatty acid beta-oxidation defect characterized by accumulation of long-chain hydroxyacylcarnitine intermediates and female carriers of this disorder are in risk for pregnancy complications." | 7.76 | Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy - a common feature of the pregnancy complication? ( Eskelin, PM; Laitinen, KA; Tyni, TA, 2010) |
| "We reported an 18-year-old woman with anorexia nervosa and liver damage who showed carnitine deficiency." | 7.69 | [A case of secondary carnitine deficiency due to anorexia nervosa and severe liver damage]. ( Fukusako, T; Kato, M; Morimatsu, M; Negoro, K; Tsuda, N, 1995) |
| "Fraternal twins who had fasting hypoglycemia, hypoketonemia, muscle weakness, and hepatic dysfunction are reported." | 5.27 | Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. ( Bier, DM; Brown, BI; Dickie, M; Engel, AG; Glasgow, AM; Perry, LW; Todaro, J; Utter, MF, 1983) |
| "The aim of this study was to evaluate to what extent secondary carnitine deficiency may exist based on the prevalence of subnormal carnitine status in patients with critical illness and abnormal nutritional state." | 5.07 | Prevalence of carnitine depletion in critically ill patients with undernutrition. ( Arfvidsson, B; Hyltander, A; Lundholm, K; Sandström, R; Sjöberg, A; Wennberg, A; Wickström, I, 1992) |
| "In conclusion, our data supports a protective effect of L-carnitine against oxidative damage in hepatic ischemia-reperfusion injury in rats." | 3.79 | The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. ( Aldemır, D; Boyacioğlu, S; Çekın, AH; Gür, G; Gürsoy, M; Taşkoparan, M; Türkoğlu, S; Yilmaz, U, 2013) |
| "Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a mitochondrial fatty acid beta-oxidation defect characterized by accumulation of long-chain hydroxyacylcarnitine intermediates and female carriers of this disorder are in risk for pregnancy complications." | 3.76 | Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy - a common feature of the pregnancy complication? ( Eskelin, PM; Laitinen, KA; Tyni, TA, 2010) |
| "The goal of this study was to compare plasma L-carnitine concentrations in dogs with different liver diseases of differing severity with the plasma L-carnitine concentrations of healthy dogs." | 3.74 | Plasma L-carnitine concentration in healthy dogs and dogs with hepatopathy. ( Kaup, FJ; Neumann, S; Thuere, S; Welling, H, 2007) |
| "We reported an 18-year-old woman with anorexia nervosa and liver damage who showed carnitine deficiency." | 3.69 | [A case of secondary carnitine deficiency due to anorexia nervosa and severe liver damage]. ( Fukusako, T; Kato, M; Morimatsu, M; Negoro, K; Tsuda, N, 1995) |
| "We report a preterm infant who was prescribed an MCT formula and subsequently developed carnitine deficiency with liver dysfunction and an elevation of serum CK level." | 3.69 | A preterm infant with secondary carnitine deficiency due to MCT formula--effective treatment of L-carnitine. ( Arai, H; Goto, A; Ishida, A; Nakajima, W; Takada, G; Takahashi, Y; Tazawa, Y, 1994) |
| "Carnitine is an amino acid derivative that is an essential cofactor in the beta-oxidation of fatty acids." | 2.45 | Carnitine in the treatment of valproic acid-induced toxicity. ( Hantson, P; Lheureux, PE, 2009) |
| " These deal mainly with biochemical systems that are known to be affected by VPA, or with the possible idiosyncratic production of toxic VPA metabolites, especially delta 4-VPA." | 2.38 | Valproate hepatotoxicity syndrome: hypotheses of pathogenesis. ( Levy, RH; Stephens, JR, 1992) |
| "Carnitine has a critical role in energy metabolism." | 2.36 | Carnitine. ( Borum, PR, 1983) |
| " A dose-response study showed that the accumulation of long-chain acylcarnitines in serum contributes to the separation of wild-type mice undergoing APAP-induced hepatotoxicity from other mouse groups in a multivariate model." | 1.35 | Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. ( Chen, C; Gonzalez, FJ; Idle, JR; Krausz, KW; Shah, YM, 2009) |
| "Acylcarnitine profiles were obtained for each specimen as butylated derivatives using tandem mass spectrometry." | 1.33 | Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects. ( Bennett, MJ; Fuda, F; Narayan, SB; Squires, RH, 2006) |
| "Carnitine is an essential cofactor in the transfer of long-chain fatty acids across the inner mitochondrial membrane for oxidation." | 1.31 | Plasma and liver carnitine status of children with chronic liver disease and cirrhosis. ( Aydogdu, S; Huseyinov, A; Selimoglu, MA; Yagci, RV, 2001) |
| "Carnitine metabolism was studied in 79 patients with chronic liver disease, including 22 patients with noncirrhotic liver disease and 57 patients with different types of cirrhosis (22 patients with hepatitis B- or C-associated cirrhosis, 15 patients with alcohol-induced cirrhosis, 15 patients with primary biliary cirrhosis [PBC], and 5 patients with cryptogenic cirrhosis), and compared with 28 control subjects." | 1.30 | Carnitine metabolism in patients with chronic liver disease. ( Krähenbühl, S; Reichen, J, 1997) |
| "Idiopathic hepatic lipidosis was diagnosed in 11 cats." | 1.28 | Treatment of idiopathic hepatic lipidosis in cats: 11 cases (1986-1987). ( Allen, S; Cornelius, L; Greene, C; Jacobs, G, 1989) |
| "Fraternal twins who had fasting hypoglycemia, hypoketonemia, muscle weakness, and hepatic dysfunction are reported." | 1.27 | Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. ( Bier, DM; Brown, BI; Dickie, M; Engel, AG; Glasgow, AM; Perry, LW; Todaro, J; Utter, MF, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (19.64) | 18.7374 |
| 1990's | 16 (28.57) | 18.2507 |
| 2000's | 18 (32.14) | 29.6817 |
| 2010's | 9 (16.07) | 24.3611 |
| 2020's | 2 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, X | 2 |
| Shi, L | 1 |
| Chen, R | 1 |
| Zhao, Y | 2 |
| Ren, D | 1 |
| Yang, X | 4 |
| Wu, Q | 1 |
| Li, X | 1 |
| Ma, R | 1 |
| Liu, Y | 1 |
| Kang, L | 1 |
| He, R | 1 |
| Song, J | 1 |
| Ren, J | 1 |
| Li, Y | 1 |
| Huang, M | 1 |
| Men, J | 1 |
| Yang, Y | 1 |
| Moghaddas, A | 1 |
| Dashti-Khavidaki, S | 1 |
| Lu, Y | 1 |
| Li, W | 2 |
| Çekın, AH | 1 |
| Gür, G | 1 |
| Türkoğlu, S | 1 |
| Aldemır, D | 1 |
| Yilmaz, U | 1 |
| Gürsoy, M | 1 |
| Taşkoparan, M | 1 |
| Boyacioğlu, S | 1 |
| Zhang, R | 1 |
| Guo, J | 1 |
| Shao, H | 1 |
| Chen, C | 1 |
| Krausz, KW | 1 |
| Shah, YM | 1 |
| Idle, JR | 1 |
| Gonzalez, FJ | 1 |
| Lheureux, PE | 1 |
| Hantson, P | 1 |
| Kaji, S | 1 |
| Murayama, K | 1 |
| Nagata, I | 1 |
| Nagasaka, H | 1 |
| Takayanagi, M | 1 |
| Ohtake, A | 1 |
| Iwasa, H | 1 |
| Nishiyama, M | 1 |
| Okazaki, Y | 1 |
| Harashima, H | 1 |
| Eitoku, T | 1 |
| Yamamoto, M | 1 |
| Matsushita, H | 1 |
| Kitamoto, K | 1 |
| Sakata, S | 1 |
| Katayama, T | 1 |
| Sugimoto, S | 1 |
| Fujimoto, Y | 1 |
| Murakami, J | 1 |
| Kanzaki, S | 1 |
| Shiraki, K | 1 |
| Al-Dirbashi, OY | 1 |
| Fisher, L | 1 |
| McRoberts, C | 1 |
| Siriwardena, K | 1 |
| Geraghty, M | 1 |
| Chakraborty, P | 1 |
| Eskelin, PM | 1 |
| Laitinen, KA | 1 |
| Tyni, TA | 1 |
| Hoofnagle, JH | 1 |
| Sarkar, S | 1 |
| Zhou, L | 1 |
| Wang, Q | 1 |
| Yin, P | 1 |
| Xing, W | 1 |
| Wu, Z | 1 |
| Chen, S | 1 |
| Lu, X | 1 |
| Zhang, Y | 1 |
| Lin, X | 1 |
| Xu, G | 1 |
| Zeidán, Q | 1 |
| Strauss, M | 1 |
| Porras, N | 1 |
| Anselmi, G | 1 |
| Spaniol, M | 1 |
| Kaufmann, P | 1 |
| Beier, K | 1 |
| Wüthrich, J | 1 |
| Török, M | 1 |
| Scharnagl, H | 1 |
| März, W | 1 |
| Krähenbühl, S | 2 |
| BALL, CR | 1 |
| Bok, LA | 1 |
| Vreken, P | 1 |
| Wijburg, FA | 1 |
| Wanders, RJ | 2 |
| Gregersen, N | 1 |
| Corydon, MJ | 1 |
| Waterham, HR | 1 |
| Duran, M | 2 |
| Spiekerkoetter, U | 1 |
| Huener, G | 1 |
| Baykal, T | 1 |
| Demirkol, M | 1 |
| Wanders, R | 1 |
| Nezu, J | 1 |
| Mayatepek, E | 1 |
| Fuda, F | 1 |
| Narayan, SB | 1 |
| Squires, RH | 1 |
| Bennett, MJ | 1 |
| Nakao, M | 1 |
| Kono, N | 1 |
| Adachi, S | 1 |
| Ebara, S | 1 |
| Adachi, T | 1 |
| Miura, T | 1 |
| Yamaji, R | 1 |
| Inui, H | 1 |
| Nakano, Y | 1 |
| Neumann, S | 1 |
| Welling, H | 1 |
| Thuere, S | 1 |
| Kaup, FJ | 1 |
| Igoudjil, A | 1 |
| Abbey-Toby, A | 1 |
| Begriche, K | 1 |
| Grodet, A | 1 |
| Chataigner, K | 1 |
| Peytavin, G | 1 |
| Maachi, M | 1 |
| Colin, M | 1 |
| Robin, MA | 1 |
| Lettéron, P | 1 |
| Feldmann, G | 1 |
| Pessayre, D | 1 |
| Fromenty, B | 1 |
| Björnsson, E | 1 |
| Borum, PR | 2 |
| Bamji, MS | 1 |
| Glasgow, AM | 1 |
| Engel, AG | 1 |
| Bier, DM | 1 |
| Perry, LW | 1 |
| Dickie, M | 1 |
| Todaro, J | 1 |
| Brown, BI | 1 |
| Utter, MF | 1 |
| Fukusako, T | 1 |
| Negoro, K | 1 |
| Tsuda, N | 1 |
| Kato, M | 1 |
| Morimatsu, M | 1 |
| Sewell, AC | 2 |
| Bender, SW | 1 |
| Wirth, S | 1 |
| Münterfering, H | 1 |
| Ijlist, L | 1 |
| Chanda, S | 2 |
| Mehendale, M | 1 |
| Ishida, A | 1 |
| Goto, A | 1 |
| Takahashi, Y | 1 |
| Nakajima, W | 1 |
| Arai, H | 1 |
| Tazawa, Y | 1 |
| Takada, G | 1 |
| Eaton, S | 1 |
| Record, CO | 1 |
| Bartlett, K | 1 |
| Mehendale, HM | 1 |
| Böhles, H | 1 |
| Wenzel, D | 1 |
| Reichen, J | 1 |
| Schmid, A | 1 |
| Schmid, H | 1 |
| Altunbaşak, S | 1 |
| Baytok, V | 1 |
| Tasouji, M | 1 |
| Hergüner, O | 1 |
| Burgut, R | 1 |
| Kayrin, L | 1 |
| Ballaban-Gil, K | 1 |
| Callahan, C | 1 |
| O'Dell, C | 1 |
| Pappo, M | 1 |
| Moshé, S | 1 |
| Shinnar, S | 1 |
| Miki, C | 1 |
| Mayer, AD | 1 |
| Buckels, JA | 1 |
| Iriyama, K | 1 |
| Suzuki, H | 1 |
| McMaster, P | 1 |
| Platell, C | 1 |
| Kong, SE | 1 |
| McCauley, R | 1 |
| Hall, JC | 1 |
| Treem, WR | 1 |
| Bohan, TP | 1 |
| Helton, E | 1 |
| McDonald, I | 1 |
| König, S | 1 |
| Gazitt, S | 1 |
| Sugimoto, T | 1 |
| Scheffner, D | 1 |
| Cusmano, L | 1 |
| Li, S | 1 |
| Koch, G | 1 |
| Selimoglu, MA | 1 |
| Aydogdu, S | 1 |
| Yagci, RV | 1 |
| Huseyinov, A | 1 |
| Btaiche, IF | 1 |
| Khalidi, N | 1 |
| DeVivo, DC | 1 |
| Stanley, CA | 1 |
| Sunaryo, F | 1 |
| Hale, DE | 1 |
| Bonnefont, JP | 1 |
| Demaugre, F | 1 |
| Saudubray, JM | 1 |
| Stephens, JR | 1 |
| Levy, RH | 1 |
| Wennberg, A | 1 |
| Hyltander, A | 1 |
| Sjöberg, A | 1 |
| Arfvidsson, B | 1 |
| Sandström, R | 1 |
| Wickström, I | 1 |
| Lundholm, K | 1 |
| Jacobs, G | 2 |
| Cornelius, L | 2 |
| Keene, B | 1 |
| Rakich, P | 1 |
| Shug, A | 1 |
| Allen, S | 1 |
| Greene, C | 1 |
| Palombo, JD | 1 |
| Jenkins, RL | 1 |
| Trey, C | 1 |
| Bistrian, BR | 1 |
| Hearn, TJ | 1 |
| Coleman, AE | 1 |
| Lai, JC | 1 |
| Griffith, OW | 1 |
| Cooper, AJ | 1 |
| Bowyer, BA | 1 |
| Fleming, CR | 1 |
| Ilstrup, D | 1 |
| Nelson, J | 1 |
| Reek, S | 1 |
| Burnes, J | 1 |
| Cotariu, D | 1 |
| Zaidman, JL | 1 |
| DiPalma, JR | 1 |
| DiMauro, S | 1 |
| Scott, C | 1 |
| Penn, AS | 1 |
| Rowland, LP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Adding Lamotrigine to Sodium Valproate in Childhood Epilepsy: Clinicolabratory Study[NCT05881928] | Phase 4 | 50 participants (Anticipated) | Interventional | 2023-07-25 | Not yet recruiting | ||
| Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants[NCT00711763] | 1 participants (Actual) | Observational | 2008-07-31 | Terminated (stopped due to failure to recruit more patients and lack of supporting personnel.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for carnitine and Liver Diseases
| Article | Year |
|---|---|
L-Carnitine and Potential Protective Effects Against Ischemia-Reperfusion Injury in Noncardiac Organs: From Experimental Data to Potential Clinical Applications.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carnitine; Female; Gastrointestinal Diseases; Human | 2018 |
Carnitine in the treatment of valproic acid-induced toxicity.
Topics: Animals; Anticonvulsants; Antidotes; Carnitine; Chemical and Drug Induced Liver Injury; Energy Metab | 2009 |
Hepatotoxicity associated with antiepileptic drugs.
Topics: Acetylcysteine; Animals; Anticonvulsants; Autoimmune Diseases; Carnitine; Chemical and Drug Induced | 2008 |
Carnitine.
Topics: Animals; Biological Transport; Carnitine; Energy Metabolism; Heart Diseases; Humans; Kidney Diseases | 1983 |
Nutritional and health implications of lysine carnitine relationship.
Topics: Animals; Carnitine; Glycine Hydroxymethyltransferase; Heart Diseases; Humans; Kidney Diseases; Liver | 1984 |
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Cardiomyopathies; Carnitine; Clinical Enzyme Tests; Fatal Outcome; | 1994 |
[Possibilities and limitations of drugs to protect the liver].
Topics: Amino Acids; Animals; Biotin; Carnitine; Fructosediphosphates; Glucose; Immunologic Factors; Ketoglu | 1996 |
Branched-chain amino acids.
Topics: Amino Acids, Branched-Chain; Brain; Carnitine; Exercise; Glutamic Acid; Humans; Intestinal Mucosa; L | 2000 |
New developments in the pathophysiology, clinical spectrum, and diagnosis of disorders of fatty acid oxidation.
Topics: Acetyl Coenzyme A; Carnitine; Fatty Acids; Female; Fetal Diseases; Humans; Infant; Lipid Metabolism, | 2000 |
Parenteral nutrition-associated liver complications in children.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bilirubin; Carnitine; Child; Cholestasis; gamma-Glutamy | 2002 |
Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.
Topics: Ammonia; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Humans; Liver; Liver Diseases; | 1992 |
Valproic acid and the liver.
Topics: Amino Acids; Carnitine; Chemical and Drug Induced Liver Injury; Drug Interactions; Fatty Acids; Huma | 1988 |
3 trials available for carnitine and Liver Diseases
| Article | Year |
|---|---|
The effect of carnitine supplementation in valproate-induced hyperammonaemia.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Carnitine; Chemical and Drug Induced Liver Injury; Chil | 1996 |
Prevalence of carnitine depletion in critically ill patients with undernutrition.
Topics: Aged; Carnitine; Critical Illness; Female; Hemofiltration; Humans; Kidney Diseases; Liver Diseases; | 1992 |
Blood carnitine status after orthotopic liver transplantation in patients with end-stage liver disease.
Topics: Carnitine; Energy Intake; Erythrocytes; Humans; Liver Diseases; Liver Transplantation | 1989 |
41 other studies available for carnitine and Liver Diseases
| Article | Year |
|---|---|
Chlorogenic acid inhibits trimethylamine-
Topics: Animal Feed; Animals; Carnitine; Chlorogenic Acid; Disease Models, Animal; Gastrointestinal Microbio | 2021 |
Topics: Animals; Bacteria; Carnitine; Gastrointestinal Microbiome; Humans; Interleukin-1; Interleukin-6; Liv | 2019 |
One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency.
Topics: Acyl-CoA Dehydrogenase, Long-Chain; Asian People; Carnitine; China; Congenital Bone Marrow Failure S | 2020 |
Soluble soybean polysaccharides enhance the protective effects of genistein against hepatic injury in high l-carnitine-fed mice.
Topics: Animals; Carnitine; Genistein; Glycine max; Humans; Lipid Metabolism; Liver; Liver Diseases; Male; M | 2017 |
The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carnitine; Disease Models, Animal; Gluta | 2013 |
Protective effect of R. glutinosa oligosaccharides against high L-carnitine diet-induced endothelial dysfunction and hepatic injury in mice.
Topics: Animals; Bacillus; Biomarkers; Body Weight; Carnitine; Diet; Disease Models, Animal; Endothelium; Li | 2016 |
Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity.
Topics: Acetaminophen; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Chromatography, Liquid; C | 2009 |
Fluctuating liver functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II.
Topics: Carnitine; Child, Preschool; Electron Transport Complex II; Fatal Outcome; Humans; Infant; Liver; Li | 2009 |
Identification of a neonate with hepatorenal tyrosinemia by combined routine newborn screening for succinylacetone, acylcarnitines and amino acids.
Topics: Amino Acids; Carnitine; Heptanoates; Humans; Infant, Newborn; Kidney Diseases; Liver Diseases; Neona | 2010 |
Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy - a common feature of the pregnancy complication?
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acute Disease; Adult; Carnitine; Fatty Liver; Female; Humans; Lipi | 2010 |
Fatigue and serum carnitine levels in chronic liver disease.
Topics: Carnitine; Chronic Disease; Fatigue; Humans; Liver Diseases; Severity of Illness Index | 2011 |
Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases.
Topics: Carcinoma, Hepatocellular; Carnitine; Chromatography, Liquid; Chronic Disease; Fatty Acids; Humans; | 2012 |
Differential long-term subcellular responses in heart and liver to adriamycin stress. Exogenous L-carnitine cardiac and hepatic protection.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cardiomyopathies; Carnitine; Chemical and Drug | 2002 |
Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate.
Topics: Acyl-CoA Oxidase; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Electron Transport; Ke | 2003 |
ACTIONS OF BETAINE, CARNITINE AND CHOLINE ON THE PATTERN OF HEPATIC LIPOSIS IN MICE FED A HIGH-FAT, LOW-PROTEIN DIET.
Topics: Animals; Betaine; Carnitine; Choline; Diet, High-Fat; Diet, Protein-Restricted; Dietary Fats; Dietar | 1964 |
Short-chain Acyl-CoA dehydrogenase deficiency: studies in a large family adding to the complexity of the disorder.
Topics: Amino Acid Substitution; Anemia, Hemolytic; Butyryl-CoA Dehydrogenase; Carnitine; Consanguinity; DNA | 2003 |
Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2.
Topics: Adult; Brain Diseases; Carnitine; Carrier Proteins; Child, Preschool; Fibroblasts; Homozygote; Human | 2003 |
Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
Topics: Bile; Biopsy; Carnitine; Fatty Acids; Humans; Infant; Liver Diseases; Oxidation-Reduction | 2006 |
Abnormal increase in the expression level of proliferating cell nuclear antigen (PCNA) in the liver and hepatic injury in rats with dietary cobalamin deficiency.
Topics: Alanine Transaminase; Animals; Biomarkers; Body Weight; Carnitine; Cell Proliferation; Growth Disord | 2006 |
Plasma L-carnitine concentration in healthy dogs and dogs with hepatopathy.
Topics: Animals; Carnitine; Dog Diseases; Dogs; Female; Health; Liver Diseases; Male; Retrospective Studies | 2007 |
High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice.
Topics: Adipose Tissue, White; Administration, Oral; Aminoisobutyric Acids; Animals; Carnitine; Chemical and | 2007 |
Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet.
Topics: Cardiomyopathies; Carnitine; Dietary Fats; Diseases in Twins; Female; Humans; Hypoglycemia; Infant; | 1983 |
[A case of secondary carnitine deficiency due to anorexia nervosa and severe liver damage].
Topics: Adolescent; Anorexia Nervosa; Carnitine; Female; Humans; Liver Diseases | 1995 |
Role of nutritional fatty acid and L-carnitine in the final outcome of thioacetamide hepatotoxicity.
Topics: Analysis of Variance; Animals; Carnitine; Cell Division; Chemical and Drug Induced Liver Injury; Die | 1994 |
A preterm infant with secondary carnitine deficiency due to MCT formula--effective treatment of L-carnitine.
Topics: Carnitine; Creatine Kinase; Humans; Infant Food; Infant, Newborn; Infant, Premature; Infant, Prematu | 1994 |
Investigation of beta-oxidation in human liver biopsies.
Topics: Biopsy, Needle; Carnitine; Chromatography, High Pressure Liquid; Coenzyme A; Esters; Humans; Liver; | 1993 |
Role of nutrition in the survival after hepatotoxic injury.
Topics: Administration, Oral; Animals; Carnitine; Chemical and Drug Induced Liver Injury; Diet; Drinking; Gl | 1996 |
Carnitine metabolism in patients with chronic liver disease.
Topics: Adult; Aged; Bilirubin; Carnitine; Chronic Disease; Humans; Liver Cirrhosis; Liver Diseases; Middle | 1997 |
Asymptomatic hyperammonemia in children treated with valproic acid.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Carnitine; Child; Child, Preschool; Epilepsy; Female; H | 1997 |
Complications of the ketogenic diet.
Topics: Adolescent; Carnitine; Child; Child, Preschool; Combined Modality Therapy; Epilepsy; Follow-Up Studi | 1998 |
Serum hepatocyte growth factor as an index of extensive catabolism of patients awaiting liver transplantation.
Topics: Adult; Aged; Amino Acids; Amino Acids, Branched-Chain; Biomarkers; Blood Glucose; Carnitine; Case-Co | 1999 |
Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carnitine; Chemical and Drug Induced Liver Injury; | 2001 |
Plasma and liver carnitine status of children with chronic liver disease and cirrhosis.
Topics: Adolescent; Adult; Carnitine; Child; Child, Preschool; Chronic Disease; Female; Hepatolenticular Deg | 2001 |
Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
Topics: Anticonvulsants; Carnitine; Chemical and Drug Induced Liver Injury; Epilepsy; Humans; Liver Diseases | 2002 |
Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency.
Topics: Blood Glucose; Carnitine; Carnitine O-Palmitoyltransferase; Fatty Acids, Nonesterified; Heart Rate; | 1992 |
Comparison of plasma, liver, and skeletal muscle carnitine concentrations in cats with idiopathic hepatic lipidosis and in healthy cats.
Topics: Animals; Carnitine; Cat Diseases; Cats; Female; Lipidoses; Liver; Liver Diseases; Male; Muscles; Mus | 1990 |
Treatment of idiopathic hepatic lipidosis in cats: 11 cases (1986-1987).
Topics: Animals; Carnitine; Cat Diseases; Cats; Enteral Nutrition; Female; Gastrostomy; Lipidoses; Liver Dis | 1989 |
Effect of orally administered L-carnitine on blood ammonia and L-carnitine concentrations in portacaval-shunted rats.
Topics: Acetates; Administration, Oral; Ammonia; Animals; Brain; Carnitine; Drug Administration Schedule; Li | 1989 |
Plasma carnitine levels in patients receiving home parenteral nutrition.
Topics: Adolescent; Adult; Aged; Carnitine; Child; Energy Intake; Fatty Acids; Female; Humans; Hyperbilirubi | 1986 |
L-carnitine: its therapeutic potential.
Topics: Carnitine; Chemical Phenomena; Chemistry; Diagnosis, Differential; Heart Diseases; Humans; Kidney Di | 1986 |
Serum carnitine. An index of muscle destruction in man.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Carbon Isotopes; Carnitine; Ch | 1973 |